Cingulate Stock (NASDAQ: CING) stock price, news, charts, stock research, profile.
Open | $0.868 |
Close | - |
Volume / Avg. | 536.000 / 309.080K |
Day Range | 0.868 - 0.868 |
52 Wk Range | 0.750 - 23.798 |
Market Cap | $5.493M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 35 |
Short Interest | 0.84% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cingulate (NASDAQ: CING) through any online brokerage.
Other companies in Cingulate’s space includes: 60 Degrees (NASDAQ:SXTP), Universe Pharmaceuticals (NASDAQ:UPC), Sonoma Pharmaceuticals (NASDAQ:SNOA), Palisade Bio (NASDAQ:PALI) and Hepion Pharmaceuticals (NASDAQ:HEPA).
The latest price target for Cingulate (NASDAQ: CING) was reported by HC Wainwright & Co. on Friday, January 5, 2024. The analyst firm set a price target for 8.00 expecting CING to rise to within 12 months (a possible 780.57% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Cingulate (NASDAQ: CING) is $0.9085 last updated Today at April 26, 2024 at 8:20 AM EDT.
There are no upcoming dividends for Cingulate.
Cingulate’s Q1 earnings are confirmed for Wednesday, May 8, 2024.
There is no upcoming split for Cingulate.
Cingulate is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.